Page 108 - NobleCon19revC2_Neat

Health Care
Date November 21, 2023 Health Care
52wk High $20.95
52wk Low $5.69 Helius Medical Technologies HSDT $6.54
642 Newtown Yardley Road
Newtown, PA 18940

(USD - in millions) heliusmedical.com
Market Cap 4.6
Enterprise (1.9)
Basic Shares Out. 0.71 COMPANY OVERVIEW
Float 0.65
Institutional Holdings 6.35% Detailed Analysis:Channelchek.com
Short Interest 0.07
Avg. 90-Day Volume 0.38 Noble Capital Markets research on Helius Medical Technologies is
published under ticker symbols HSDT and HSM:CA. The price target is
in USD and based on ticker symbol HSDT.
Helius Medical Technologies is a neurotech company focused on
EPS Data neurological wellness. The Company’s purpose is to develop, license
and acquire unique and non-invasive platform technologies that amplify
2021 2022 2023 the brain’s ability to heal itself. The Company’s first commercial product
CQ1 (82.50) (57.50) (4.50) is the Portable Neuromodulation Stimulator (PoNSTM).
CQ2 (129.00) (48.50) (3.00)

CQ3 (100.50) (6.00) (5.49)
CQ4 (65.50) (8.50) (3.64)
CY (369.00) (52.00) (12.86) Source: Channelchek/QuoteMedia

Long-Term EPS Estimate N/A
Price/Book (mrq) 4.39
ROE (ttm) -158.82
Debt-to-Total Cap. (mrq) 2.26
Fiscal Year End 31-Dec

642 Newtown Newtown PA 18940

Key Executives
CEO: Andreeff, Dane
CFO: Mathiesen, Jeffrey
COO: N/A
IR: N/A
Noble Capital Markets, Inc.
Source: Capital IQ, Noble Financial estimates, company filings
Noble Senior Analyst 561-994-1191 noblecapitalmarkets.com
Robert LeBoyer MEMBERS: FINRA, SIPC, MSRB
Following the conference, complete video library of presentations will be
rleboyer@noblelsp.com available at: channelchek.com | nobleconference.com
(212) 896-4625

Refer to the back of the book for disclosures